Arama

EISSN 2475-0581

IMPACT FACTOR: 0.5 INDEXED IN WEB OF SCIENCE

Psychiatry and Clinical Psychopharmacology

HIGHLY CITED ARTICLES

The Effect of COVID-19 Pandemic on Psychosomatic Complaints and Investigation of The Mediating Role of Intolerance to Uncertainty, Biological Rhythm Changes and Perceived COVID-19 Threat in this Relationship: A Web-Based Community Survey

by Gıca et al.

COVID-19 Vaccine Hesitancy and Its Relationship With Illness Risk Perceptions, Affect, Worry, and Public Trust: An Online Serial Cross-Sectional Survey From Turkey

by Kucukkarapinar et al.

Evaluation of the Psychiatric Research Output From Turkey Via Web of Science Database: A Bibliometric Analysis

by Topal et al.

High Doses of Second-Generation Long-Acting Antipsychotics in the Treatment of Patients with Severe Resistant Schizophrenia: A Six-Year Mirror-Image Study

by Fernandez- Miranda et al.

Video/Computer Game Addiction Among University Students in Ghana: Prevalence, Correlates and Effects of Some Demographic Factors

by Miezah et al.

Burnout, Job Satisfaction, and Psychological Symptoms Among Emergency Physicians During COVID-19 Outbreak: A Cross-Sectional Study

by Bahadırlı and Sağaltıcı.

Parental Attachment and the Theory of Mind Abilities as Predictors of Internet Addiction in Turkish Adolescents

by Akdeniz et al.

Investigating the Impact of the ECT on Thiol-Disulphide Homeostasis in Depressive Disorders

by Atagün et al.

Comparison of Drugs Prescribed by Psychiatrists and Child/Adolescent Psychiatrists

by Aydin et al.

Adaptation of Internet Gaming Cognition Scale to Turkish: Reliability and Validity Study

by Cakiroglu and Soylu.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 22 results

Ranking

Release Date Sort Sort Article Type

Psychiatric Diagnoses and Prescribing Patterns of Psychotropic Polypharmacy among Children and Adolescents in the Jazan Region, Saudi Arabia

Abdulkarim M. Meraya

( Psychiatry and Clinical Psychopharmacology 2020; 30: 24-30) DOI: 10.5455/PCP.20200320091656

Abstract Full Text ( PDF) Related Articles

Does Combined Antipsychotic Treatment Provide Better Control on Symptoms in Patients with Schizophrenia than the Monotherapy?

Ersin Karslioglu, Elvan Ozalp, Ismail Sahiner, Mehmet Ozturk, Melike Albayrak, Serap Aydin, Sadik Aydin, Ozgur Yuncu, Ali Caykoylu

( Psychiatry and Clinical Psychopharmacology 2016; 26: 39-47) DOI: 10.5455/bcp.20150629110950

Abstract Full Text ( PDF) Related Articles

A Case of Chronic Schizophrenia Who were Switched from Combined Treatment to Monotherapy and Achieved a Decrease in Positive Symptoms after Lowering the Clozapine Dose

Hayriye Hamurcu, Ali Caykoylu, Eda Peksen, Mehmet Ozturk, Neslihan Sevil

( Psychiatry and Clinical Psychopharmacology 2016; 26: 324-328) DOI: 10.5455/bcp.20130127023102

Abstract Full Text ( PDF) Related Articles

Psychiatric Diagnoses and Prescribing Patterns of Psychotropic Polypharmacy among Children and Adolescents in the Jazan Region, Saudi Arabia

Does Combined Antipsychotic Treatment Provide Better Control on Symptoms in Patients with Schizophrenia than the Monotherapy?

A Case of Chronic Schizophrenia Who were Switched from Combined Treatment to Monotherapy and Achieved a Decrease in Positive Symptoms after Lowering the Clozapine Dose

Is Depression a Predictive Factor for Polypharmacy in Elderly?

Prescribing trends in treatment-resistant schizophrenia

The prevalence of metabolic syndrome in outpatients with severe mental illness in antipsychotic monotherapy or polypharmacy

Risk of psychotropic drug interactions in real world settings: a pilot study in patients with schizophrenia and schizoaffective disorder

Antipsychotic polypharmacy versus monotherapy in elderly patients with chronic schizophrenia: a clinical trial

Psychotropic drug use in a child and adolescent inpatient psychiatry clinic

Frequency of antipsychotic polypharmacy in schizophrenic outpatients

Frequency of antipsychotic polypharmacy in schizophrenic outpatients

Polypharmacy is a need in psychiatric practice

Comparison of polypharmacy in schizophrenia and other psychotic disorders in outpatient and inpatient treatment periods: a naturalistic one year follow-up study

Combination treatments in schizophrenia

Causes of antipsychotic polypharmacy in schizophrenia treatment

Development of neuroleptic malignant syndrome after addition of sertraline to the treatment: A case report

Combined antipyschotic prescription for inpatients: A retrospective study

Psychopharmacology Antipsychotic treatment of patients who are recorded in Corum Community Mental Health Center with the diagnosis of psychotic disorders

Psychopharmacology Frequency of antipsychotic polypharmacy in schizophrenic outpatients

A case report of chronic schizophrenia: From combined treatment to monotherapy and decrease in positive symptoms with decreasing dose of clozapine

Comparison of antipsychotic prescribing in the treatment of schizophrenia between the years of 2004-2009

Polypharmacy in psychiatry practice